Celgene Collaborates With Array BioPharma On Cancer, Inflammation Targets
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal does not include candidates already in Array’s pipeline, firm tells “The Pink Sheet” DAILY.
You may also be interested in...
Celgene To Collaborate With VentiRx On TRL8 Receptor Agonist For Cancer
VentiRx’s immunotherapy approach has created a compound, VTX-2337, offering potential in a variety of cancers and complementary to numerous standard-of-care backbones.
Array Analgesic Meets Primary, Secondary Endpoints In Phase II Pain Management Trial
Positive results from a second trial in post-surgical dental pain could lead to plans for broader indication.
Array Analgesic Meets Primary, Secondary Endpoints In Phase II Pain Management Trial
Positive results from a second trial in post-surgical dental pain could lead to plans for broader indication.